_________willadvise the CWif the patientmeets bridgingcriteriaVelsipityshould bestored at___________Onecommonside effect ofVelsipity is_________Anothercommon sideeffect of Velsipityis_____________State one pre-treatmentserviceavailable topatients______Velsipity isadministeredvia___________Each blisterpack ofVelsipitycontains_____or_____tabletsFCM mustescalate to______forapproval if apatient does notmeet criteriaThe genericname ofVelsipity is___________If more than___consecutivedoses are missednotify HCP fortreatment re-initiation____________isa very commonadverse reactionThe Velsipitywelcome call isperformedby__________Patients with_________should haveregular eyeexamsSome patientsrequire a__________thefirst time theytake VelsipityPatientswith__________should haveregular eyeexamsPatients shouldnot_______theirdose of Velsipityto make up for aforgotten doseTherecommendeddoseofVelsipity is______Each bottle ofVelsipity willcontain______tabletsVelsipity hassimilarprogramofferings to____________Long-termbridging may beapproved for_______monthsThemechanismof action ofVelsipity is___________Velsipity isindicated fortreating___________UC is a chronicinflammatorydisease thataffectsthe________List onesymptom ofUC__________________willadvise the CWif the patientmeets bridgingcriteriaVelsipityshould bestored at___________Onecommonside effect ofVelsipity is_________Anothercommon sideeffect of Velsipityis_____________State one pre-treatmentserviceavailable topatients______Velsipity isadministeredvia___________Each blisterpack ofVelsipitycontains_____or_____tabletsFCM mustescalate to______forapproval if apatient does notmeet criteriaThe genericname ofVelsipity is___________If more than___consecutivedoses are missednotify HCP fortreatment re-initiation____________isa very commonadverse reactionThe Velsipitywelcome call isperformedby__________Patients with_________should haveregular eyeexamsSome patientsrequire a__________thefirst time theytake VelsipityPatientswith__________should haveregular eyeexamsPatients shouldnot_______theirdose of Velsipityto make up for aforgotten doseTherecommendeddoseofVelsipity is______Each bottle ofVelsipity willcontain______tabletsVelsipity hassimilarprogramofferings to____________Long-termbridging may beapproved for_______monthsThemechanismof action ofVelsipity is___________Velsipity isindicated fortreating___________UC is a chronicinflammatorydisease thataffectsthe________List onesymptom ofUC_________

Velsipity BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. _________will advise the CW if the patient meets bridging criteria
  2. Velsipity should be stored at ___________
  3. One common side effect of Velsipity is _________
  4. Another common side effect of Velsipity is _____________
  5. State one pre-treatment service available to patients______
  6. Velsipity is administered via ___________
  7. Each blister pack of Velsipity contains _____or _____tablets
  8. FCM must escalate to ______for approval if a patient does not meet criteria
  9. The generic name of Velsipity is ___________
  10. If more than ___consecutive doses are missed notify HCP for treatment re-initiation
  11. ____________is a very common adverse reaction
  12. The Velsipity welcome call is performed by__________
  13. Patients with _________ should have regular eye exams
  14. Some patients require a __________the first time they take Velsipity
  15. Patients with__________ should have regular eye exams
  16. Patients should not _______their dose of Velsipity to make up for a forgotten dose
  17. The recommended doseof Velsipity is ______
  18. Each bottle of Velsipity will contain ______tablets
  19. Velsipity has similar program offerings to ____________
  20. Long-term bridging may be approved for _______months
  21. The mechanism of action of Velsipity is ___________
  22. Velsipity is indicated for treating ___________
  23. UC is a chronic inflammatory disease that affects the________
  24. List one symptom of UC_________